Topics

SIM Partners Company Profile

07:52 EDT 21st September 2019 | BioPortfolio

SIM Partners’ local marketing automation technology, Velocity, maximizes digital marketing results for enterprise brands from multiple industries at a local level. In the healthcare industry, Velocity makes location data actionable and local content scalable to drive patient acquisition for healthcare systems across multiple locations and physician networks. With Velocity, healthcare systems can create location-based content to turn “near me” mobile searches into offline visits. Velocity includes a powerful local data management tool to drive listing visibility, a content management system that automates the creation of location-based strategies that help healthcare systems manage the patient journey effectively. SIM Partners has offices in Chicago and San Francisco. To learn more, or request a demo, visit www.simpartners.com.


News Articles [284 Associated News Articles listed on BioPortfolio]

Pharvaris gets $66mm via Series B

Cardiovascular-focused start-up Pharvaris BV raised $66mm in its Series B financing round led by led by Foresite Capital, which was joined by Bain Capital Life Sciences, venBio Partners, and Venrock P...

AI-powered risk prediction platform KenSci secures $22M

Polaris Partners led the Series B round, and Ignition Partners, Osage University Partners, Mindset Ventures and UL Ventures also participated.

Lifespan tries to keep Partners out of RI. I’m quoted in the Boston Globe

Big bad Partners HealthCare plans to take over Rhode Island’s number two player, Care New England. Lifespan, the market leader is trying to keep Partners out by appealing to Rhode Islanders’ resen...

ABIVAX Completes €12 Million Capital Raise Entirely Subscribed by Sofinnova Partners at Market Price

Abivax cash runway extended to end of Q2, 2020 - Sofinnova Partners strengthens and diversifies Abivax shareholder base - Sofinnova Partners to join the Board of Directors - Proceeds to be used fo...

AM-Pharma closes €116mm Series F round

AM-Pharma BV raised €116mm ($133mm) through its Series F round co-led by new investors LSP (Life Sciences Partners) and Andera Partners. Returning backers Forbion, Ysios Capital, Kurma Partners, IDI...

Molecular Partners und Addex werden an Cowen-Konferenz Pipeline vorstellen

Zürich (awp) - Mit Molecular Partners und Addex haben gleich zwei Schweizer Biotechfirmen ihre Teilnahmen an der Cowen-Investorenkonferenz in Boston diese Woche angekündigt. Molecular Partners will....

Boston Business Journal quotes David Williams on Partners CEO departure

Boston Business Journal quoted David Williams about the sudden departure of Partners HealthCare CEO, Dr. David Tochiana: “(Torchiana) tried to rationalize the organization and make Partners into a r...

MorphoSys unverändert unter Beschuss von Shortseller AHL Partners

Planegg (www.aktiencheck.de) - Leerverkäufer AHL Partners LLP stockt Netto-Leerverkaufsposition in MorphoSys-Aktien weiter deutlich auf: Die Leerverkäufer von AHL Partners LLP halten die Aktien des....

Drugs and Medications [66 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [respiratory care partners, inc]

Oxygen

Moderiba [abbvie inc.]

These highlights do not include all the information needed to use Moderiba (ribavirin, USP) safely and effectively. See full prescribing information for Moderiba (ribavirin, USP). Moderiba (ribavirin,...

Ribavirin [sandoz inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useIniti...

Ribavirin [richmond pharmaceuticals, inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitia...

Ribavirin [aurobindo pharma limited]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral use Init...

PubMed Articles [234 Associated PubMed Articles listed on BioPortfolio]

Adolescents' Contraceptive Use with School-Discordant Partners: Exploring Individual- and Relationship-Level Characteristics.

Heterosexual adolescents are less likely to use contraceptives when their partners are of different backgrounds or social circles. It is unclear why risky behaviors are more common within these relati...

Psychological interventions targeting partners of cancer patients: A systematic review.

Cancer patients' intimate partners often experience levels of psychological burden that are comparable to or even exceed that of the patients, making it imperative that they too be provided with appro...

Relationship Satisfaction of Intimate Partners of Persons Living With Urinary Incontinence.

The purpose of this study was to examine effects of urinary incontinence (UI) on midlife women's relationships with their intimate partners, from the perspective of both women and their partners.

Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification.

Multiple sclerosis (MS), a demyelinating condition of the central nervous system with an unpredictable course, has a major impact on the lives of people with MS. Partners of people with MS may be sign...

'Man in the driving seat': a grounded theory study of the psychosocial experiences of Black African and Black Caribbean men treated for prostate cancer and their partners.

Evidence suggests that treatment side-effects of prostate cancer (CaP) substantially affect the psychosocial well-being of affected men and their partners. However, this phenomenon is poorly understoo...

Clinical Trials [403 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Teachers and Parents as Partners During Middle School RCT

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Companies [965 Associated Companies listed on BioPortfolio]

SageCreek Partners

SageCreek Partners is creating and driving a new category of service: Mentor Capital. Working as a companion to technology companies and their investment partners and boards, Sage...

Paragon Technology Partners, LLP

Paragon Technology Partners was founded by Heather Burke of Chicago, IL and Amanda C. Ratliff of Delaware, OH. The two partners have a deep desire to build top-quality networks an...

Health Partners Plans (HPP)

Nationally recognized for its innovations in managed care, Health Partners Plans consistently receives the highest ratings for member and provider satisfaction and, is currently r...

BC Partners

BC Partners is a leading international investment firm with over €20 billion of assets under management in private equity, private credit and real estate. Established in 1986, BC Partners has pl...

Prospect Partners, LLC

Prospect Partners is a leading private equity firm investing in smaller lower-middle-market companies, managing $470 million across three funds. A highly experienced and active in...

More Information about "SIM Partners" on BioPortfolio

We have published hundreds of SIM Partners news stories on BioPortfolio along with dozens of SIM Partners Clinical Trials and PubMed Articles about SIM Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SIM Partners Companies in our database. You can also find out about relevant SIM Partners Drugs and Medications on this site too.

Quick Search

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record